. Long-term prognosis for transplant-free survivors of paracetamol-induced acute liver failure.
Summary
Background: The prognosis for transplant-free survivors of paracetamol-induced acute liver failure is unknown.
Aim: To examine whether paracetamol-induced acute liver failure increases long-term mortality.
Methods:
We followed all transplant-free survivors of paracetamol-induced acute liver injury hospitalized in a Danish national referral center during 1984-2004. We compared age-specific mortality rates from one year post-discharge through 2008 between those in whom the liver injury led to an acute liver failure and those in whom it did not.
Results:
We included 641 patients. On average, age-specific mortality rates were slightly higher for the 101 patients whose paracetamol-induced liver injury had caused an acute liver failure (adjusted mortality rate ratio = 1.70, 95% CI 1.02-2.85), but the association was age-dependent, and no survivors of acute liver failure died from liver disease, whereas suicides were frequent in both groups. These observations speak against long-term effects of acute liver failure. More likely, the elevated mortality rate ratio resulted from incomplete adjustment for the greater prevalence of substance abuse among survivors of acute liver failure.
Conclusions: Paracetamol-induced acute liver failure did not affect long-term mortality. Clinical follow-up may be justified by the cause of the liver failure, but not by the liver failure itself. 
Introduction
Acute liver failure is an immediately life-threatening condition that in Denmark and many other countries is caused primarily by paracetamol poisoning (1) (2) (3) . The treatment strategy-securing patient survival until effective liver regeneration takes over and resorting to liver transplantation if this strategy fails-relies on the assumption that the liver is capable of complete regeneration leading to clinical recovery (4) (5) (6) . The purpose of our study was to evaluate this assumption by studying long-term mortality among survivors of paracetamol-induced acute liver failure.
A recent case series suggested that non-paracetamol drug-induced liver injury with jaundice could play a role in the long-term risk of chronic liver disease, but without a comparison group a firm conclusion could not be reached (7) . The choice of comparison group is critical because it is difficult to disentangle the long-term effects of the acute liver failure from the confounding effects of the other characteristics of patients who develop acute liver failure. Hence we restricted our study to patients at risk of acute liver failure, viz. patients with severe paracetamol-induced liver injury.
Among them, we compared post-discharge mortality between those who had or had not experienced an acute liver failure. To corroborate the necessity of using restriction to reduce confounding, we also compared the mortality of patients with paracetamol-induced liver injury without acute liver failure with the mortality in the general population. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Materials and methods

Study population
Patient data
We used data from the patients' medical charts to ascertain the diagnosis of acute liver failure, defined by coagulopathy, jaundice, and hepatic encephalopathy grade 2-4 (9 and ischemic heart disease (ICD-8: 41x.xx; ICD-10: I20.x to I25.x). These conditions were considered present from the date of the first hospital discharge with the diagnosis.
Mortality data
Dates of death were obtained from the Central Office of Civil Registration, where data are updated continuously with no loss to follow-up (10) . Causes of death were ascertained from the Cause of Death Registry, which contains information on up to four events or medical conditions that led to death for each decedent. The data are supplied by the physician responsible for the patient's treatment at the time of death (11) . We reviewed the registered data to define a single cause of death for each patient; the investigators were blinded to patients' acute liver failure status.
Statistical analyses
Follow-up began one year after the date of discharge following paracetamol-induced liver injury and ended at death or on 31 December 2008, whichever came first. The 1-year delay in follow-up was introduced to avoid bias due to early deaths related to the poisoning or its psychiatric cause (e.g. risk of completed suicide is particularly high up to one year after a paracetamol poisoning) (12) . We used the Mann-Whitney test for the continuous variables, i.e. patient age and calendar time, and Pearson's chi-square test for the other variables to test the hypotheses that patients with or We compared the mortality rate ratio (specifically, the hazard ratio) for patients with and without acute liver failure using Cox proportional hazards regression, and we adjusted for the effects of gender, calendar year, alcohol abuse, other substance abuse, schizophrenia or use of antipsychotics, affective disorder or use of antidepressants, borderline personality disorder, eating disorder, cancer, chronic obstructive lung disease, diabetes, arterial hypertension, and ischemic heart disease.
Because we followed patients from a time point defined by recovery from acute paracetamolinduced liver injury, we anticipated that patient age was a stronger predictor of death than time since hospital discharge, and therefore a more relevant time scale for our analyses (13) . Using natural splines, we plotted the age-specific adjusted mortality rate ratios for acute liver failure (14) .
Comparison with population mortalit y Through the Central Office of Civil Registration we identified a control group from the general population, the aim being to substantiate the excess mortality for patients hospitalized for paracetamol-induced liver injury. We included 100 gender-, age-, and calendar time-matched Danish citizens per patient without acute liver failure, and they were drawn at random using risk set sampling (15) . Using Cox regression and natural splines, as described above, we plotted the agespecific mortality rate ratios for the general population sample vs. patients with paracetamolinduced liver injury without liver failure.
Results
We included 641 transplant-free survivors of paracetamol-induced liver injury, and 101 (16%) of these had acute liver failure. Among the patients with acute liver failure, 16% had hepatic encephalopathy of grade 2; 51% of grade 3; and 33% of grade 4. The median follow-up time was Patients with acute liver failure were more likely than patients without acute liver failure to be female, and they were older, and more likely to abuse alcohol and other substances (Table 1) . Also the age-specific prevalence of substance abuse was higher among patients with a history of acute liver failure than among patients without such history. For example, at age 45 the prevalence of alcohol abuse was 58% in the acute liver failure group (14 of 24 patients under observation) compared with 29% in the group with milder liver injury (29 of 101 patients under observation) ( Table 2 ).
On average, age-specific mortality rates were higher for patients with a history of acute liver failure (adjusted mortality rate ratio = 1.70, 95% CI 1.02 to 2.85). However, the mortality rate ratio was strongly age-dependent, so that 25-, 45-, or 75-year-old people who had more than one year previously been hospitalized with paracetamol-induced acute liver failure had higher mortality than equal-age people who had more than one year previously been hospitalized with paracetamolinduced acute liver injury without liver failure, and vice versa among 35-or 60-year-old people (Figure 1) . However, the earlier temporary failure of liver function was not the cause of the excess mortality: no patient with a history of acute liver failure was recorded to die from liver disease (data on causes of death were unavailable for three decedents). By contrast, six patients without acute liver failure died from acute or chronic liver disease. Suicides were very frequent in both groups (26 suicides = 37% of the 76 deaths with data on causes of death), as were accidents, cancer, and cardiovascular disease (Table 3) .
Mortality before age 60 years was clearly higher for patients with a history of paracetamol-induced liver injury without acute liver failure than for the general population sample (Figure 1) . Hence, the 
Discussion
We followed transplant-free survivors of paracetamol-induced liver injury and found that those who had suffered an acute liver failure had marginally higher mortality, but for causes not attributable to their earlier liver failure. We also showed that survivors of paracetamol-induced liver injury younger than 60 years of age had a markedly higher mortality than the general population, largely due to suicides and accidents.
It is a long-standing and basic assumption that there is complete clinical recovery after a reversible loss of liver function. This assumption is rooted in the well-known regenerative capacity of the liver, but it has not previously been challenged by a long-term clinical follow-up study. Our data support the classical assumption. We found a marginal increase in mortality after acute liver failure, but it was age-dependent and not due to liver-related deaths. Rather, we expect the association to be an overestimate due to incomplete control of confounding by substance abuse, which was only crudely measured as absent or present.
The validity of the clinical diagnoses of acute liver failure is crucial because invalid diagnoses would have led us to underestimate the true effect of acute liver failure (16) . However, we believe that the diagnoses were valid because they were made by specialists in a liver transplantation center and required clinically overt hepatic encephalopathy, i.e. grade 2-4.
The findings in our study accord with a recent follow-up study in which patients with and without hepatotoxic paracetamol overdose had parallel survival curves from one year after hospital (17) . In that study, however, at most only 15 deaths were observed more than one year after hospital discharge. Likewise, a study of post-discharge liver biopsies from patients with paracetamol-induced liver injury supplied histological evidence of reversibility (6), and complete regeneration has also been described after surgical liver injury in animals and humans (4, 5) and after severe toxic liver injury in rats (18) .
Our comparison with mortality in the general population is consistent with our previous findings that, for several years after hospitalization for paracetamol poisoning, the risks of being diagnosed with a psychiatric disease and/or completing suicide are greatly elevated (12, 19) . Our analyses also demonstrate that a general population sample is not the proper comparison group for evaluating long-term effects of acute liver injury: those pre-existing patient characteristics that lead to experiencing an acute liver injury, in casu from paracetamol overdose, heavily influence prognosis.
Therefore we conducted the study within a cohort of patients with a history of paracetamol-induced liver injury and excluded those who died within a year post-discharge. These design features minimized confounding from patient characteristics such as suicidal intent as opposed to therapeutic misadventure, because we can expect similar characteristics-82% with suicidal intent-in equalage Danish patients with or without acute liver failure after paracetamol poisoning (20) .
In conclusion, paracetamol-induced acute liver failure did not increase long-term mortality, but many patients hospitalized for paracetamol-induced liver injury eventually completed suicide.
Hence our findings reiterate that all patients hospitalized for paracetamol-induced liver injury should undergo psychiatric evaluation and follow-up, whereas follow-up by hepatologists is not indicated.
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